Go to deals
TMT

Horoquartz has been acquired by Amano

The shareholders of Horoquartz have sold the company to Japan-based Amano for US$73 million. The deal involved 100% cash at completion.

Horoquartz is a market leader in time and scheduling software solutions, offering companies and public organizations agile tools necessary to facilitate the relationship between the employer and its employees.

Amano offers a diverse range of solutions for the effective use of human resources, from the basic time recorders to the latest network attendance management systems. Amano will support Horoquartz's expansion in Europe taking advantage of the technology in Japan.

Oaklins' team in France advised the seller in this transaction.

Parties

Talk to the deal team

Thibaut de Monclin

Managing Partner
Paris, France
Oaklins France

Hadrien Mollard

Managing Partner
Paris, France
Oaklins France

Related deals

BodhiCedric has acquired Network Media from Jellysmack
TMT

BodhiCedric has acquired Network Media from Jellysmack

The media holding company BodhiCedric has acquired Network Media, an innovator in the creator economy, from Jellysmack, the global creator company.

Learn more
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
TMT

CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions

Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.

Learn more
Bayer AG has entered into a takeover agreement with Cara Care
Healthcare | TMT

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Learn more